| Recruitment status | Preinitiation |
| Unique ID issued by UMIN | UMIN000030337 |
| Receipt No. | R000034446 |
| Official scientific title of the study | Evaluation of robot assisted laparoscopic radical cystectomy |
| Date of disclosure of the study information | 2018/02/01 |
| Last modified on | 2017/12/11 (Ver. 1) |
| Basic information | ||
| Official scientific title of the study | Evaluation of robot assisted laparoscopic radical cystectomy | |
| Title of the study (Brief title) | Evaluation of robot assisted laparoscopic radicalcystectomy | |
| Region |
|
|
| Condition | ||
| Condition | Invasive Bladder cancer | |
| Classification by specialty |
|
|
| Classification by malignancy | Malignancy | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | Evaluate the effectiveness and safety of robot-assisted total cystectomy using the da Vinci surgical system (DVSS) for patients with advanced bladder cancer, in whom total cystectomy is indicated. |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Intraoperative bleeding volume |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Historical |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Robot-assisted laparoscopic cystectomy | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1) Transurethral bladder tumor resection was performed, and from the pathological findings it is a bladder cancer patient diagnosed as requiring bladder total resection.
2) Abdominal contrast CT or MRI has been diagnosed as resectable. 3) It is under 80 years old. 4) The age at the time of consent acquisition is over 20 years old. 5) For patient participation, written consent has been obtained from the patient himself. |
|||
| Key exclusion criteria | 1) Patient have active duplicated cancers.
2) Hemorrhagic diathesis or discontinuation of anticoagulant is impossible. 3) Patients with morbid obesity (Body mass Index: BMI>35. 4) Mental illness or psychiatric symptoms are merged, and judgment of participation in the examination is judged difficult. 5) It is a patient who may be pregnant or may be pregnant. 6) Patients with severe complications (liver disease, kidney disease, heart disease, lung disease, blood disease, autoimmune failure etc). 7) For other reasons, the investigator or test sharing doctor of the medical institution participating in this study (hereinafter referred to as the medical institution to be conducted) judges that participation in this exam is ineligible. |
|||
| Target sample size | 10 | |||
| Research contact person | |
| Name of lead principal investigator | Nasu Yasutomo |
| Organization | Okayama University |
| Division name | Urology |
| Address | Shikatacho 2-5-1 okayama |
| TEL | 0862357287 |
| kobayasu@md.okayama-u.ac.jp | |
| Public contact | |
| Name of contact person | Kobayashi Yasuyuki |
| Organization | Okayama University |
| Division name | Urology |
| Address | Shikatacho 2-5-1 okayama |
| TEL | 0862357287 |
| Homepage URL | |
| kobayasu@md.okayama-u.ac.jp | |
| Sponsor | |
| Institute | Okayama university |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Okayama university |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Preinitiation | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000034446 |